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Abstract: Under physiological and pathological conditions, vascular smooth muscle cells (SMC) are exposed to different 
biochemical factors and biomechanical forces. Previous studies pertaining to SMC responses have not investigated the 
effects of both factors on SMCs. Thus, in our research we investigated the combined effects of growth factors like bFGF 
(basic fibroblast growth factor), TGF- (transforming growth factor ) and PDGF (platelet-derived growth factor) along 
with physiological cyclic strain on SMC responses. Physiological cyclic strain (10% strain) significantly reduced SMC 
proliferation compared to static controls while addition of growth factors bFGF, TGF- or PDGF-AB had a positive 
influence on SMC growth compared to strain alone. Microarray analysis of SMCs exposed to these growth factors and 
cyclic strain showed that several bioactive genes (vascular endothelial growth factor, epidermal growth factor receptor, 
etc.) were altered upon exposure. Further work involving biochemical and pathological cyclic strain stimulation will help 
us better understand the role of cyclic strain and growth factors in vascular functions and development of vascular 
disorders. 
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1. INTRODUCTION 
  Recent studies have demonstrated that biomechanical 
factors like cyclic strain and shear stress play a major role in 
normal vascular function and early development of vascular 
diseases [1-4]. Particularly, previous efforts investigating 
effects of cyclic strain on SMC functions found that cyclic 
strain could regulate both normal cellular functions and 
pathophysiological changes. For instance, pathological 
cyclic strain (>15%) increases DNA synthesis by increasing 
reactive oxygen species (ROS) production and activation of 
NF-kB in cultured SMCs [5] while physiological levels of 
cyclic strain (10% strain) inhibit SMC growth by increasing 
cyclin-dependent kinase inhibitor p21 and promoting 
apoptosis [6, 7]. One study suggests that “physiological 
stretch” maintains SMCs in quiescent state and “pathological 
stretch” initiates SMC proliferation [8]. These studies 
indicate that physiological cyclic strain contributes to 
vascular homeostasis by inhibiting cell cycle and enhancing 
apoptosis, while overstretching leads to intimal thickening 
by stimulating SMC growth.  
  In addition to cyclic strain, biochemical factors such as 
growth factors also play an important role in SMC responses, 
and the SMC response to growth factors is also well-studied. 
For instance, studies have shown bFGF to be an important 
mitogen while PDGF acts as a chemotactic agent in SMC 
proliferation [9-11]. Research has also shown TGF- to be a  
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potent antiproliferative and proliferative molecule for SMCs 
depending on its concentration [12, 13]. Of all these growth 
factors, it is well known that PDGF can enhance the SMC 
growth under static conditions [14, 15]. In addition, studies 
have shown that SMC growth is altered at different levels by 
cyclic strain and is determined by the amplitude and 
frequency of strain, by stimulating the expression and 
production of various growth factors, such as fibroblast 
growth factor-2 (FGF-2) [11, 16], PDGF [17], and insulin-
like growth factor 1  (IGF-1) [18]. Furthermore, growth 
factor receptors such as epidermal growth factor receptor 
(EGFR) and protease activated receptor-1 (PAR-1) are also 
activated by cyclic strain [19, 20], leading to the induction of 
cell proliferation.  
  This research aims to investigate SMC responses to 
cyclic strain in the presence of growth factors (bFGF, TGF- 
or PDGF-AB). bFGF and TGF- were selected as the 
biochemical stimulants as an increased amount of these 
growth factors has been found in regions of atherosclerotic 
plaques [21-28]. Studies have also shown that an increased 
amount of PDGF is seen at sites of atherosclerotic plaques 
[14, 29]. Pilot studies were conducted to determine the 
optimal concentrations of each growth factor for enhanced 
cell proliferation and were used later in our experiments. In 
addition, 10% cyclic strain was selected for our studies as 
this strain level is within the range of normal physiological 
conditions. To investigate SMC responses to both 
physiological cyclic strain and growth factors, SMC 
proliferation and gene expression were determined using 
PicoGreen DNA assays and cDNA microarrays 
(Affymetrix). 
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2. MATERIALS AND METHODS 
2.1. Concentration of Growth Factor Used in Studies 
  Human Aortic Smooth Muscle Cells (HASMC, Cascade 
Biologics, OR) were grown and maintained at 37
0C in 
Dulbecco’s Modified Eagle Medium (DMEM) (Invitrogen, 
NY), supplemented with 10% fetal bovine serum (FBS) 
(HyClone, UT). Cells between passages 5-10 were seeded at 
10
4 cells/cm
2 in 24-well plates and fed quiescent media 
(DMEM supplemented with 2% FBS) for 2 days. On day 3, 
cells were fed with different concentrations (0-90 ng/ml) of 
the growth factor (bFGF, TGF- or PDGF – all three 
isoforms) in quiescent media. After 72 hours of exposure, 
PicoGreen DNA assay was performed to generate a growth 
curve to determine the optimal concentration of each growth 
factor.  
2.2. SMC Proliferation Studies 
  Cells were seeded at 10
4 cells/cm
2 on type I collagen-
coated flexible membranes and grown for two days in 
quiescent media. Cells were exposed to cyclic strain (10 % 
strain at 60 cycles/min) by the FlexCell cyclic strain system 
in the presence or absence of growth factors at their optimal 
concentrations (30 ng/ml for bFGF, 15 ng/ml for TGF- and 
15 ng/ml for PDGF-AB) for 3 days. After experiments, cells 
were lysed with 1% Triton X-100 and total cell DNA was 
analyzed using PicoGreen DNA assay (Molecular Probes) 
following the manufacturer’s instructions. HASMCs cultured 
on membranes and not subjected to cyclic strain served as 
static controls. 
2.3. RNA Isolation and Microarray Analysis 
  After exposure to cyclic strain with or without bFGF, 
TGF- and PDGF-AB, HASMCs were rinsed quickly with 
cold PBS and total RNA was isolated using TRIZOL reagent 
(Invitrogen) according to the manufacturer’s instructions. 
Qualities of RNA samples were determined by 
spectrophotometric analysis (OD 260/280) and agarose gel 
electrophoresis as described previously [30]. Microarray 
(Affymetrix) processing of RNA samples was done at 
Microarray Facility in the Center for Integrated BioSystems 
at Utah State University. After processing, microarrays were 
scanned for gene expression using microarray analysis suite 
software (Affymetrix). Bioconductor tools [31] were used to 
apply both nonspecific and specific filters. The nonspecific 
filter identified genes with coefficient of variance (sd/mean, 
taken across all arrays) between 0.3 and 10. A specific filter 
was applied to these genes, restricting attention to those 
involved in specific cellular (proliferation, inflammation, and 
apoptosis) and molecular (signal transduction) function gene 
ontologies. After filtering, genes with absolute fold change 
of 2 or more were selected for further investigation. Those 
selected genes were clustered and their functions in the 
various signaling pathways were analyzed using the online 
tool DAVID (Database for Annotation, Visualization, and 
Integrated Discovery) and the KEGG (Kyoto Encyclopedia 
of Genes and Genomes).  
2.4. Statistical Analysis 
  Analysis of the results was performed using t-tests with p 
< 0.05. For each study, the sample size was 3-6 (n=3-6) and 
the results are presented as mean ± standard deviation (SD).  
3. RESULTS 
3.1. Effects of Growth Factors (bFGF, TGF- and PDGF) 
on SMC Proliferation 
  For pilot studies, different concentrations (0-90 ng/ml) of 
bFGF, TGF- and the three isoforms (-AA, -BB and –AB) of 
PDGF were investigated for optimal concentration for SMCs 
growth. We found maximal proliferation of SMCs at a 
concentration of 15 ng/ml of TGF-, PDGF-AB and PDGF-
AA while maximum proliferation was seen at concentrations 
of 30 ng/ml of bFGF and 60 ng/ml of PDGF-BB. In case of 
PDGF, the isoform PDGF-AB showed the highest efficacy 
by exhibiting approximately 80% more SMC proliferation 
compared to the static controls while the isoforms PDGF-BB 
and PDGF-AA both showed about 20% more proliferation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Effect of the growth factors bFGF, TGF- and the three isoforms of PDGF on SMC proliferation under static conditions. (n=6; *: p 
< 0.05 vs. static controls). 30    The Open Biomedical Engineering Journal, 2009, Volume 3  Kona et al. 
than the static control. With TGF-, SMCs exhibited about 
40% increase in growth and with bFGF the increase in 
growth was about 30%. All the growth factors (bFGF, TGF-
 and PDGF) increased the proliferation of SMCs after 3 
days in culture (Fig. 1), indicating that these growth factors 
exhibit a positive effect on SMCs growth. 
3.2. Effects of Cyclic Strain and Growth Factors (bFGF, 
TGF- and PDGF) on SMC Proliferation 
  As indicated in Fig. (2), physiological level of cyclic 
strain (10%) significantly reduced SMC proliferation (~60% 
of the static controls, p<0.05). However, treatment with 
bFGF, TGF- and PDGF while cells were under cyclic strain 
showed a positive influence on SMC growth when compared 
to cells exposed to cyclic strain only (p<0.05). TGF- and 
PDGF-AB in particular showed ~90% SMC proliferation in 
comparison to 60% for SMCs exposed to only cyclic strain. 
An interesting finding was that PDGF isoforms exhibited 
different effects on SMC proliferation on exposure to cyclic 
strain. Under physiological cyclic strain, PDGF-AA further 
reduced SMC proliferation (~ 45%) while PDGF-AB and 
PDGF-BB increased SMC proliferation compared to the 
static control and cyclic strain. Between the two, PDGF-AB 
still showed the highest efficacy for enhancing cell growth, 
showing even higher cell proliferation than the static control. 
Although these growth factors diminish the behavior of 
cyclic strain-reduced cell growth, SMC growth is similar 
with the static samples excluding PDGF-AA (Figs. 1, 2). 
3.3. Effects of Cyclic Strain on Gene Expressions of SMC 
  After filtering, microarray data showed that 11 genes 
were up-regulated and 7 genes were down-regulated when 
cells are exposed to 10% cyclic strain compared to cells 
under static controls (Table 1). Under cyclic strain, SOCS3 
(an inhibitor in the JAK-STAT signaling pathway) was 
down-regulated (~3 fold). Expression of a receptor of tumor 
necrosis factor (TNF) – TNFRSF19 and the Fas – Fas 
apoptotic inhibitory molecule 2 (anti-apoptosis) were also 
reduced. Also, three anti-apoptotic genes (FAIM2, 
SERPINB9 and SOCS3) were down-regulated by a factor of 
two to three. These results indicate that cyclic strain alters 
the expression of some genes associated with apoptosis that 
lead to decreased SMC proliferation. 
3.4. Effects of Growth Factors bFGF, TGF- and PDGF-
AB on Gene Expression of SMCs Under Cyclic Strain 
  Comparing the results of the effect of cyclic strain and 
growth factor (bFGF, TGF- or PDGF-AB) on gene 
expression with those of the cells exposed to 10% cyclic 
strain, an increase in number of genes regulated (Table 2-4) 
was observed. For example, there was an increased up-
regulation of various interleukins (ILs), especially both IL-1 
 and IL-1  when cyclic strain was combined with growth 
factors (Table 2-4). Also, the expression of various factors 
(prostaglandin, VEGF and EGFR) was also induced. 
Furthermore, combination of cyclic strain with bFGF or 
TGF- also increased down-regulation of genes involved in 
suppression of cytokine signaling (SOCS3, SOCS2), 
apoptosis and regulation of cell growth (tumor necrosis 
factors, heat shock protein 1B, serin peptidase inhibitor) and 
molecules related to cell adhesion like collagen type 1. When 
SMC’s were exposed to PDGF-AB under cyclic strain, 
EREG, a gene encoding epirgulin (a member of the 
epidermal growth factor family), and VEGF, which encodes 
the vascular endothelial growth factor, were up-regulated 
three folds. In contrast, cyclic strain alone regulated only a 
small number of bioactive genes in SMCs compared to static 
controls (Table 1). 
3.5. Effects of both Cyclic Strain and Growth Factors on 
Signaling Pathways in SMCs 
  Both cyclic strain and growth factors regulated several 
signaling molecules in SMCs in our studies. Results from 
DAVID and KEGG charts indicated both cyclic strain and 
growth factors regulated various molecules involved with 
cytokine-cytokine receptor interactions, MAPK and JAK-
STAT signaling pathways (Figs. 3,  4). For example, JNK 
and p38 MAPK were found as potential signaling pathways 
when cells were exposed to both cyclic strain and growth 
factors (Fig. 3). Genes involved with regulation of cell 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Effects of bFGF, TGF- and three PDGF isoforms on SMC proliferation under cyclic strain. (n=6; *: p < 0.05 vs. static control (C); 
**: p < 0.05 vs. cyclic strain (S)). Effects of Cyclic Strain and Growth Factors  The Open Biomedical Engineering Journal, 2009, Volume 3    31 
Table 1.  Effects of Cyclic Strain on Gene Expression in SMCs Versus Static Culture 
FUNCTION GENE  DESCRIPTION  FOLD  CHANGE 
IL1RN  interleukin 1 receptor antagonist  2.86 
AOX1  aldehyde oxidase 1  2.33 
HDAC9  Histone deacetylase 9  2.20 
IL1RN  interleukin 1 receptor antagonist  2.17 
AOX1  aldehyde oxidase 1  2.09 
IRF7  interferon regulatory factor 7  -2.23 
Inflammation 
CXCL12  chemokine (C-X-C motif) ligand 12  -2.86 
IL1B  interleukin 1, beta  3.24 
IL1A  interleukin 1, alpha  2.83 
SCIN Scinderin  2.28 
Proliferation 
EREG Epiregulin  2.21 
HIPK2  homeodomain interacting protein kinase 2  1.99 
F2R  coagulation factor II (thrombin) receptor  -1.99 
Apoptosis 
TNFRSF19  TNF receptor superfamily, member 19  -2.19 
SERPINB2  serpin peptidase inhibitor, clade B (ovalbumin), member 
2 
2.05 
SERPINB9  serpin peptidase inhibitor, clade B, member 9  -2.06 
SOCS3  suppressor of cytokine signaling 3  -3.12 
Anti-Apoptosis 
FAIM2  Fas apoptotic inhibitory molecule 2  -3.33 
 
Table 2.  Differential Gene Expression in SMCs Exposed to Cyclic Strain and bFGF Versus Static Culture 
FUNCTION GENE  DESCRIPTION  FOLD  CHANGE 
IL1RN  interleukin 1 receptor antagonist  2.88 
CXCL5  chemokine (C-X-C motif) ligand 5  2.30 
CCL8  chemokine (C-C motif) ligand 8  2.23 
MGLL monoglyceride  lipase  2.22 
GPR68  G protein-coupled receptor 68  2.16 
TNF  IP6  Tumor Necrosis Factor alpha-induced protein 6  -2.30 
CXCL12  chemokine (C-X-C motif) ligand 12  -3.42 
Inflammation 
IL1R1  interleukin 1 receptor, type I  -2.41 
IL1  interleukin 1, beta  3.80 
EREG epiregulin  3.54 
EGFR  epidermal growth factor receptor  3.01 
TP53  tumor protein p53 (Li-Fraumeni syndrome)  -2.08 
Proliferation 
SERPINE2  serpin peptidase inhibitor, clade E, member 2  -2.23 
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(Table 2). Contd….. 
FUNCTION GENE  DESCRIPTION  FOLD  CHANGE 
CASP1  caspase 1, apoptosis-related cysteine peptidase  -2.01 
PLAGL1  pleiomorphic adenoma gene-like 1  -2.15 
PLAGL1  pleiomorphic adenoma gene-like 1  -2.27 
TPD52L1  tumor protein D52-like 1  -2.55 
TPD52L1  tumor protein D52-like 1  -2.94 
SULF1 sulfatase  1  -3.58 
Apoptosis 
TNFRSF11B  TNF-receptor superfamily, member 11b  -4.23 
BCL2A1  BCL2-related protein A1  2.99  Anti-Apoptosis 
ANGPTL4 angiopoietin-like  4  2.85 
 
Table 3.  Differential Gene Expression in SMCs Exposed to Cyclic Strain and TGF  Versus Static Culture 
FUNCTION  GENE  DESCRIPTION  FOLD CHANGE 
PTGS2  prostaglandin-endoperoxide synthase 2  4.96 
VEGF  vascular endothelial growth factor  3.42 
IL1  interleukin 1, beta  2.37 
OLR1  oxidised low density lipoprotein  2.72 
EGFR  epidermal growth factor receptor  2.32 
SMURF2  SMAD specific E3 ubiquitin protein ligase 2  2.26 
IL6  interleukin 6 (interferon, beta 2)  2.25 
AOX1  aldehyde oxidase 1  -2.13 
PTX3  pentraxin-related gene  -2.15 
NFATC4  nuclear factor of activated T-cells  -2.20 
CXCL2  chemokine (C-X-C motif) ligand 2  -2.31 
C3  complement component 3  -2.42 
CD14  CD14 antigen  -2.47 
IL1R1  interleukin 1 receptor, type I  -2.53 
BDKRB2  bradykinin receptor B2  -2.67 
IL17D  interleukin 17D  -2.69 
IL1R1  interleukin 1 receptor, type I  -2.71 
IL17D  interleukin 17D  -2.84 
Inflammation 
CXCL12  chemokine (C-X-C motif) ligand 12  -4.30 
IL1  interleukin 1, alpha  3.86  Proliferation 
EREG  Epiregulin (negative regulation of cell proliferation)  2.05 
TP53  tumor protein p53 (Li-Fraumeni syndrome)  -2.29  Apoptosis 
CD14  CD14 antigen  -2.47 
BCL2A1  BCL2-related protein A1  2.59  Anti-Apoptosis 
RASA1  RAS p21 protein activator (GTPase activating protein) 1  2.08 
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Table 4.  Differential Gene Expression in SMCs Exposed to Cyclic Strain and PDGF-AB Versus Static Culture 
FUNCTION GENE  DESCRIPTION  FOLD  CHANGE 
PTGS2  prostaglandin-endoperoxide synthase 2  7.44 
IL1B  interleukin 1, beta  5.23 
IL1A  interleukin 1, alpha  5.08 
CCL20  chemokine (C-C motif) ligand 20  4.98 
IL24 interleukin  24  3.92 
IL8 interleukin  8  3.74 
IL6  interleukin 6 (interferon, beta 2)  3.31 
IL1RN  interleukin 1 receptor antagonist  2.48 
IL17D interleukin  17D  -3.92 
IL1R1  interleukin 1 receptor, type I  -3.44 
HSPA1B  heat shock 70kDa protein 1B  -2.81 
AOX1  aldehyde oxidase 1  -2.6 
TNFAIP8  TNF, alpha-induced protein 8  -2.47 
Inflammation 
C3  complement component 3  -2.34 
EREG Epiregulin  3.1  Proliferation 
VEGF  vascular endothelial growth factor  3.07 
TP53 tumor  protein  p53  -4.81 
CASP1 caspase  1  -4.47 
CARD10  caspase recruitment domain family, 10  -3.36 
DIDO1 death  inducer-obliterator  1  -3.01 
Apoptosis 
CASP8 caspase  8  -2.88 
Anti-apoptosis  BCL2A1  BCL2-related protein A1  5.72 
 
apoptosis were also found in cells exposed to both cyclic 
strain and growth factors. For instance, genes such as 
SOCS2 and SOCS3 (suppressor of cytokine signaling) were 
regulated in most of the experimental conditions compared 
to static controls (Table 2-4). 
4. DISCUSSION AND LIMITATIONS 
  To date, combined effects of cyclic strain and growth 
factors have not been well-studied. Our current study reveals 
that physiological cyclic strain and growth factors regulate 
cell proliferation and gene expression in SMCs. Compared to 
cells exposed to cyclic strain alone, cells exposed to cyclic 
strain and bFGF, TGF- or PDGF-AB exhibited significant 
SMC proliferation, as shown by our results. Microarray 
analysis of these SMCs showed the alteration of various 
genes such as SOCS3 (an inhibitor in the JAK-STAT 
signaling pathway), TNF and FAIM2, and the potential 
involved mechanisms including MAPK, JAK-STAT and 
cytokine-cytokine receptor interaction signaling pathways. 
  Consistent with previous observations, our results 
demonstrate that cyclic strain at physiological level (10% 
strain) causes a significant decrease in cell proliferation 
compared to static culture. Physiological cyclic strain 
decreases SMC growth by inducing apoptosis through Notch 
signaling pathways [7]. Other studies have also shown that 
mitogen-activated protein kinases (MAPK) are activated 
when cultured SMCs are exposed to stretch leading to cell 
apoptosis [32-35]. Conversely, pathological stretch has been 
shown to initiate signaling pathways of nuclear factor-kappa 
B (NF-B) and reactive oxygen species (ROS), leading to 
SMC proliferation, stress-induced inflammation and 
apoptosis [33, 36-38]. 
  While physiological cyclic strain reduced SMC 
proliferation significantly, adding growth factors with cyclic 
strain diminishes this behavior in our studies. Of the studied 
growth factors, TGF- , PDGF-AB and bFGF have the most 
positive effect on SMC proliferation, and their role in SMC 
proliferation is well documented [16, 39-43]. TGF-  and 
PDGF-AB induced greater SMC proliferation compared to 
bFGF when exposed to cyclic strain, suggesting that they 
may share the same signaling pathways with cyclic strain. 
Other studies also found that bFGF induced less cell 
proliferation compared to other growth factors (PDGF-AB 
and PDGF-BB) [44].  34    The Open Biomedical Engineering Journal, 2009, Volume 3  Kona et al. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Potential roles of MAPK pathways involved with cells exposed to both cyclic strain and growth factors bFGF and TGF. *indicates 
molecules that may be involved in the process using KEGG software analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). Potential roles of JAK-STAT pathways involved with cells exposed to both cyclic strain and growth factors bFGF and TGF. 
*indicates molecules that may be involved in the process using KEGG software analysis.  Effects of Cyclic Strain and Growth Factors  The Open Biomedical Engineering Journal, 2009, Volume 3    35 
  It has been shown that cyclic strain also regulates SMC 
responses through a number of other cellular signaling 
transduction pathways like extracellular signal-regulated 
kinase 1/2 (ERK1/2) [19], ROS [5], calcium ion channels 
[45], cytoskeletal elements, focal adhesion proteins, G-
protein coupled receptors and TNF-kB [5]. Some 
experimental evidence suggests that several factors, 
including cyclic strain, growth factors and vasoactive 
substances, [35, 46-50] are responsible for SMC 
proliferation. For example, chemical factors (Ang II and 
thrombin) demonstrate additive effects with cyclic strain on 
gene regulation [8, 39]. In vivo studies have found that 
circulating growth factors along with increased cyclic strain 
cause vascular wall remodeling in hypertensive humans and 
animals [51, 52]. It is possible that cyclic strain might act as 
a co-mitogen with other artherogenic risk factors such as 
growth factors thereby altering gene expression and 
promoting SMC proliferation throughout intimal thickening. 
Therefore, it is important to investigate the effects of both 
cyclic strain and growth factors on SMC responses. 
  The microarray results demonstrate much exciting 
progress in our understanding of SMC responses to both 
cyclic strain and growth factors. However, a major challenge 
of the microarray analysis is to integrate the large data of 
gene expression to obtain the useful biomarkers or molecules 
and signaling pathways. In our study, we filtered the genes 
on the basis of cell proliferation, apoptosis, inflammation, 
and signal transduction. After filtering, our results showed 
that cyclic strain when combined with each of the growth 
factors, bFGF, PDGF-AB and TGF- , altered the expression 
of several bioactive genes and signaling molecules, as 
described in detail below. 
4.1. Genes Related to Inflammation Responses 
  Since the genes related to inflammation responses such 
as interleukins (ILs) have been shown to play an important 
role in regulation of SMC growth, these genes were selected 
in our studies. For instance, some cytokines have been 
shown to inhibit endothelial cell growth while stimulating 
SMC growth [53]. Genes involved in inflammatory 
response, especially the interleukins, are altered in SMCs 
exposed to both cyclic strain and growth factors in our 
studies. As a surprise finding, among all the interleukins, IL-
1  was up-regulated when cyclic strain was combined with 
growth factors (bFGF ~ 4 fold increase, TGF- ~2 fold, 
Tables 2-3). Interestingly, IL-1 has been reported to promote 
SMC proliferation [54, 55] and induces the transformation of 
vascular SMCs into foam cells by an increased uptake of 
unmodified LDL [56]. Besides IL-1, IL-6 that can stimulate 
SMC growth [57] was also induced ~2 fold in cells exposed 
to both cyclic strain and TGF- compared to those of static 
controls. High levels of cyclic strain (up to 20% strain) have 
been shown to induce the expression of IL-6, but not other 
interleukins (IL-1a, IL-1b, IL-10, IL-12 and IL-18) in 
previous studies [33]. These observations suggest the 
involvement of biomechanical factors with inflammation 
responses. In addition to ILs, a 5-fold increase in PTGS2 
(prostaglandin-endoperoxide synthase 2), a gene involved in 
inflammatory response and cell motility as well as in glucose 
homeostasis [58], has been observed when SMCs are 
exposed to both cyclic strain and growth factor TGF- or 
both cyclic strain and growth factor PDGF-AB. 
4.2. Genes Involved with ECM and Cell Adhesion 
  ECM proteins play a major role in cell adhesion and 
subsequent cell proliferation. Collagen, a major ECM protein 
found in plaques, is also secreted by synthetic phenotypic 
SMCs. Mechanical forces (cyclic strain/ stretch) have been 
found to produce an increase in collagen synthesis and other 
ECM proteins in cultured SMC [59]. Physiological cyclic 
strain increases the expression of collagen 2-fold only, as per 
our results. When SMCs were exposed to both bFGF and 
10% cyclic strain, expression of collagen 1 was down-
regulated by 4 times compared to static controls. Although 
ECM proteins like collagen can regulate cell adhesion, it is 
also worth to note that changes in collagen expression have 
been found to be independent with proliferation of SMCs by 
bFGF as shown by previous studies [60].  
4.3. Genes Regulating Cell Proliferation and Apoptosis 
  On exposure to cyclic strain, SMCs exhibited a decrease 
in cell proliferation. Both SOCS and STAT, which are 
involved in intracellular signaling cascade of cell apoptosis 
[61], were found in cells exposed to both cyclic strain and 
growth factors (Fig. 4). Under cyclic strain, a 2 to 3-fold 
down regulation in the expression of anti-apoptotic genes 
SERPINB9 and FAIM2 was observed. The down-regulation 
of these anti-apoptotic genes could possibly induce SMC 
apoptosis and result in less cell proliferation under cyclic 
strain than the static control. These results are in accordance 
with previous observations by Morrow et al. who found that 
physiological level cyclic strain inhibits SMC growth while 
enhancing SMC apoptosis [7]. In contrast, Chapman et al. 
claimed that cyclic stretch inhibited SMC growth only by 
blocking cell cycle progression without excess apoptosis [6]. 
The differences in findings might be due to the different 
cyclic strain exposure time and apoptosis detecting methods 
used. Reduction of endogenous FAIM expression could 
induce caspase-8 activation and cell apoptosis [62]. 
SERPINB9, also known as Proteinase Inhibitor 9 (PI-9), 
inhibits caspase-1 and thereby inhibits apoptosis [63].  
  Cyclic strain and growth factors were also found to alter 
several genes involved with cell proliferation and apotosis 
such as vascular endothelial growth factor (VEGF), EREG (a 
gene encoding epirgulin and member of the epidermal 
growth factor family) and heat shock protein. The increased 
expression of these mitogenic factors certainly could 
enhance cell proliferation. In addition, the overall 
apoptosis/anti-apoptosis gene panel was inclined to inhibit 
cell apoptosis, in other words, to enhance cell proliferation. 
VEGF plays an important role in various biological and 
cellular processes in several pathological conditions [64]. 
VEGF is also involved in inhibiting apoptosis in SMCs in 
atherosclerosis [65]. VEGF was modestly induced to 1.9-
fold by 4% strain at 12 and 24 hours in other studies [66]. 
TGF- and PDGF-AB increased VEGF expression (~3 fold) 
when combined with strain. An increased up regulation of 
the genes epiregulin and EGFR, which are responsible for 
proliferation, was also seen in our studies. 
  Different apoptotic genes, CASP1, CASP8, various 
tumor protein family genes and CARD10 were down-
regulated three to five times, while genes encoding the anti-
apoptotic factors, such as BCL2-related protein A1 
(BCL2A1), were up-regulated. BCL2A1 is a member of the 36    The Open Biomedical Engineering Journal, 2009, Volume 3  Kona et al. 
BCL-2 family and has been shown to retard apoptosis in 
various cell lines [67]. In addition to mitogenic factors and 
apoptotic/anti-apoptotic genes, the gene profile of cytokines 
is interesting to note. Several interleukins, which are known 
for their proliferative effects on SMCs, including interleukin-
1 (IL-1) [55, 68], interleukin-1 (IL-1) [54], interleukin-
6 (IL-6), and interleukin-8 (IL-8) [69], were also up-
regulated. 
  Heat shock proteins (hsp), involved in anti-apoptosis, 
protect SMCs from death and in turn stabilize the arterial 
plaques [70]. Cyclic strain levels at 10, 15 and 20% strain 
induced expression of hsp70 significantly compared to static 
controls (upto 5-fold) [71]. Cyclic strain and growth factors 
repressed HSPA1B gene expression by 2-folds while 
increasing the HSPA5 expression by 2-folds. It is hard to 
speculate that HSP plays any role in the altered proliferation 
of SMCs by both cyclic strain and growth factors because 
the induction of HSPA1B by the process is not high (just 2-
folds) and is balanced with the regression of HSPA5.  
4.4. Signal Transduction Genes 
  The gene expression results shows that when cyclic strain 
is combined with growth factors, many genes involved in 
signal transduction pathways are modulated. For example, 
genes such as SOCS2 and SOCS3 were repressed along with 
STAT1 in most of our experimental conditions. Both SOCS 
and STAT are involved in intracellular signaling cascade and 
anti-apoptosis. Recent studies show the involvement of 
SOCS3 in down-regulating the hypoxia induced PASMC 
proliferation by 50% [61]. In addition, SMURF2, shown to 
be involved in apoptosis by recruiting Rb and p53 pathways 
and in TGF- receptor signaling [72], showed a 2-fold 
increase in expression when exposed to cyclic strain and 
TGF-.  
  Results from DAVID and KEGG charts indicated both 
cyclic strain and growth factors regulated various molecules 
involved with pathways such as cytokine-cytokine receptor 
interactions, Mitogen-Activated Protein Kinase (MAPK) and 
Janus kinases-signal transducers and activators of 
transcription (JAK-STAT) signaling pathways. Although 
there is no study showing the involvement of cytokine-
cytokine receptor interactions in the cyclic strain regulation, 
various MAPK and JAK-STAT signaling molecules have 
been found to be involved with the effects of cyclic strain on 
SMCs [34, 73-76]. Previous studies demonstrate that STAT-
3, ERK1/2, and Src are involved in mediating the effects of 
cyclic strain on vascular SMCs [73]. Other studies also find 
cyclic strain-induced IL-6 expression in SMCs via 
Ras/Rac1/p38 MAPK/NF-kB signaling pathways [33].  
  Though the project collected a vast amount of gene 
expression data from cDNA microarray experiments, we had 
to use filtering mechanisms based on gene oncology. In 
addition, we did not investigate the effects of both 
pathological cyclic strain and growth factors on SMC 
responses in this current study. Despite these limitations, 
results from this project might provide insight into the 
biological aspects of SMC responses to various stimuli. 
Future studies will investigate various levels of biochemicals 
and physiological and pathological cyclic strain on SMC 
responses. A further understanding of molecular mechanisms 
involved in these SMC responses will also have important 
clinical interventions that can modify SMC proliferation, 
thereby reducing the risk for cardiovascular diseases. 
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